After a Nigerian UN peacekeeper contracted Ebola and was transported to the Netherlands for treatment, advanced decontamination technology was deployed to minimise the risk of cross-infection.

The University Medical Centre (UMC) in Utrecht called the local representative of a UK decontamination specialist to intervene on an isolation suite where the patient had been hospitalised. Using hydrogen peroxide vapour (HPV) technology, capable of eliminating 99.9999% of pathogens, Bioquell technology was used to neutralise the risks of any cross-contamination.

The Netherlands as well as other European countries have agreed to accept foreign patients as part of a European medical evacuation initiative. The UMC has four specialised beds available to receive potential Ebola sufferers.

To support UMC following the Ebola patient admission, Bioquell provided an immediate response and proceeded to carry out the decontamination on Christmas’ eve. The company’s technology has been well proven to be the solution of choice when it comes to challenging pathogen removal including post-Ebola decontamination. So far, Bioquell’s HPV process has been trusted on many occasions in the US, France, the UK as well as the Netherlands to eradicate possible traces of the virus. The technology has been used to successfully decontaminate emergency vehicles, hospital areas, transport isolators and even journalist equipment.

Commenting on the intervention, Dennis van der Zwan, Bioquell’s distributor for Benelux, said, “This is another proof that the healthcare professionals trust Bioquell and its HPV methodology when it comes to efficient bio-decontamination in times of emergency and high-risk contamination. Its ability to eliminate doubt is beyond challenge.”

more about bioquell

more news from bioquell